AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05587647 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transition to Adulthood Education Program
Description: YEGEP was developed by the authors based on the information in the literature, based on the needs of mothers of children who have reached adulthood or are going through. Three training modules are planned in line with current requirements. Education will also be supported by audio-visual and written materials. It is planned that the trainings, which will last for 3 weeks in total, for 1 hour a week for each group, in the form of 3 sessions of 1 hour with these contents, will be held at a disabled center. Titles of training modules:~1. Developmental Period Characteristics of Young Adults with Intellectual Disabilities (Transition to Adulthood, Future Planning / Social Life (employment, peers, etc.)~2. Protecting and Sustaining the Health of Young Adult with Intellectual Disabilities~3. Coping with Stress
Study NCT05404841 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: CoffeeBerry Supplement
Description: A Coffeeberry supplement containing 200mg Caffeine and 14mg polyphenols, manufactured by FutureCeuticals Inc.,
Study NCT05404841 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05076513 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Description: Participants in Arm A who move onto the Expansion cohort will receive 6-7 weeks of radiation therapy per standard of care.
Study NCT05248997 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: rimegepant 75 mg ODT
Description: One dose of rimegepant 75 mg ODT
Study NCT05248997 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Matching placebo
Description: One dose of matching placebo
Study NCT05312229 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Critical Time Intervention
Description: An evidence-based, structured, and time-limited case management practice
Study NCT06297304 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sedentary and physical activity behaviors
Description: The intervention will consist of three individual sessions, each lasting one hour, with approximately 15 days between each session. The sessions will be scheduled as follow: Week 5 and 6 (session 1), week 7 and 8 (session 2), week 9, 10, and 11 (session 3). During these sessions, subjective and objective indicators related to sedentary behaviors and the physical activity levels will be recorded to assess the progress of each student.
Study NCT04632147 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ujjayi pranayama, Nadi-Shodhana pranayama, Sukha pranayama
Description: Ujjayi pranayama:It is a pranayamic application that is performed by slightly twisting the throat and breathing through the nose. Nadi shodhana pranayama is breathing alternately through the right and left nostrils.Sukha pranayama is inhaled through the nose for 5 seconds, then given through the nose for 5 seconds. Thus, 6 times of inspiration and expiration is done per minute.
Study NCT04881539 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Description: This group will receive an oral dose of CBD (Six Degrees Wellness).
Study NCT04881539 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Cannabidiol (CBD)
Description: This group will receive an oral dose of CBD (Six Degrees Wellness).
Study NCT04803812 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote SMS (short message service, also known as text message) delivery
Description: Assessing the comparative effects of SMS types (storytelling; resources/strategies; and a combination of both) on physician wellbeing.
Study NCT06187818 — intervention group
Intervention type: DRUG
Intervention: Crocin
Description: According to the patient's condition, tolerance level, and personal preference, the dosage of medication was selected. During chemotherapy, the total anthocyanin tablets were divided into an experimental group (experimental group 1 and experimental group 2 based on previous heart disease) and a control group (control group 1 and control group 2 based on previous heart disease), 30 cases in each group \[experimental group: taking saffron total glycoside tablets for 8 days during each chemotherapy period (starting from the day before chemotherapy), 4 tablets/time, 3 times a day; control group: not taking saffron total glycoside tablets during chemotherapy period\]
Study NCT05312229 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Critical Time Intervention
Description: An evidence-based, structured, and time-limited case management practice
Study NCT05312229 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: External Facilitation
Description: Site-specific support to help sites develop tailored plans to implement CTI.
Study NCT05312229 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Replicating Effective Programs
Description: A stakeholder-informed training and technical assistance implementation strategy
Study NCT05312229 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Replicating Effective Programs
Description: A stakeholder-informed training and technical assistance implementation strategy
Study NCT05407714 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SpaceOAR Treatment
Description: SpaceOAR System is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR System to reduce the radiation dose delivered to the anterior rectum.~The SpaceOAR System is composed of biodegradable material and maintains space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient's body over time.
Study NCT05104463 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CST-2032, matching placebo for CST-2032, CST-107, matching placebo for CST-107
Description: CST-2032 and matching placebo white tablets, CST-107 and matching placebo yellow tablets
Study NCT06071234 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 3D reconstruction technology
Description: Preoperative application of 3D reconstruction technology to evaluate the breast blood supply of participants and observe whether the incidence of ischemic complications in the flap and nipple areola complex is reduced compared to surgery without preoperative evaluation.
Study NCT06071234 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 3D reconstruction technology
Description: Preoperative application of 3D reconstruction technology to evaluate the breast blood supply of participants and observe whether the incidence of ischemic complications in the flap and nipple areola complex is reduced compared to surgery without preoperative evaluation.
Study NCT04838522 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: This is a non-interventional study.
Study NCT06278415 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiological based cord clamping
Description: see Arm Description
Study NCT06278415 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Differed cord clamping
Description: see Arm Description
Study NCT05101837 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Home program
Description: Regular mindfulness guided face-to-face program, by using the technology with android to receive mindfulness sessions for daily practice and to assess the feasibility and the effectiveness of behavioural approach base on mindfulness delivered with this modality
Study NCT06517784 — intervention group
Intervention type: OTHER
Intervention: No treatment given
Description: No treatment given
Study NCT06577558 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SR1375 capsule 3mg+regular treatments
Description: SR1375 capsule 3mg QD orally+CAP regular treatments
Study NCT06577558 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SR1375 capsule 1mg+regular treatments
Description: SR1375 capsule 1mg QD orally+CAP regular treatments
Study NCT06577558 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SR1375 capsule 0.3mg+regular treatments
Description: SR1375 capsule 0.3mg QD orally+CAP regular treatments
Study NCT06577558 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsule+regular treatments
Description: Placebo capsule QD orally+CAP regular treatments
Study NCT06578559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: 500 mg/sqm intravenous infusion over 120-minute at cycle 1 (if well tolerated, it is administered over 90 minutes at second administration, and over 60 minutes by the third administration) every 14 days.
Study NCT06578559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Encorafenib
Description: 300 mg once daily (four 75 mg oral capsules).
Study NCT05667532 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Contrast Enhanced Mammography
Description: Screening Modality
Study NCT06238791 — intervention group
Intervention type: OTHER
Intervention: Presence of foot deformity, ankle range of motion, foot posture, local tissue water percentage, and foot pressure distribution will be evaluated in patients with chronic venous disease.
Description: Presence of foot deformity, ankle range of motion, foot posture, local tissue water percentage, and foot pressure distribution will be evaluated in patients with chronic venous disease and lipedema.
Study NCT05008887 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Fractional CO2 laser-assisted cutaneous delivery of methotrexate solution in stable, non-segmental vitiligo
Study NCT05008887 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-fluorouracil
Description: Fractional CO2 laser-assisted cutaneous delivery of 5-fluorouracil solution in stable, non-segmental vitiligo
Study NCT05008887 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fractional CO2 laser
Description: Fractional CO2 laser-assisted cutaneous delivery of methotrexate and 5-fluorouracil solution in stable, non-segmental vitiligo
Study NCT05008887 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Description: Fractional CO2 laser-assisted cutaneous delivery of methotrexate and 5-fluorouracil solution in stable, non-segmental vitiligo
Study NCT06485804 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Smartphone application guided exercises
Description: Participants in the intervention group will use a smartphone application to execute a self-rehabilitation program. The app will integrate:~* Basic information about neck pain and ergonomic advice.~* A series of evaluation questions on pain and function.~* Appropriate sets of exercises with videos and instructions.~* Daily reminders.~* Evaluation reports providing feedback and adherence.
Study NCT06576323 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: An implementation model for co-located Medications for Opioid Use Disorder (MOUD) prescription in the NICU
Description: We will use implementation mapping to develop a suite of implementation strategies to deliver evidence-based MOUD prescription to mothers attending the bedside of their infants hospitalized in the NICU. The intervention itself is buprenorphine induction and treatment, however the model for delivery is not yet developed, consistent with the need for results from Aim 1 to inform the approach used to develop the implementation model in Aim 2.
Study NCT06574412 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cardonilizumab combined with renvastinib
Description: Preoperative: Cardenilimab: 10 mg/kg qd intravenously, one cycle every 21 days, administered on the first day of each cycle, a total of 4 cycles. Lenvatinib: Weight \&lt;60kg, 8mg, once a day, orally, for 4 cycles Weight \&gt;60kg, 12mg, once a day, orally, for a total of 4 cycles Surgery: The patient is receiving 4 cycles of cardenilimab + Standard radical nephrectomy was performed within 30-40 days after the end of lenvatinib treatment. Postoperative: Cardenilimab: 10 mg/kg qd intravenously, 1 cycle every 21 days, administered on the 1st day of each cycle, a total of 8 cycles Lenvatinib: body weight \&lt;60 kg, 8 mg, once a day, orally , a total of 8 cycles, weight \&gt; 60kg, 12mg, once a day, orally, a total of 8 cycles.
Study NCT06575933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-1084
Description: Oral administration
Study NCT06575933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Oral administration
Study NCT06575933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Digoxin
Description: Oral administration
Study NCT05676463 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MRI-guided Intensity-Modulated Radiation Therapy
Description: Undergo MRI-guided IMRT
Study NCT05676463 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Antiandrogen Therapy
Description: Receive SOC ADT
Study NCT05676463 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PSMA PET Scan
Description: Undergo PSMA PET scan
Study NCT05676463 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT05676463 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05676463 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Scan
Description: Undergo bone scan
Study NCT05676463 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05676463 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT06575946 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Vestibular Hypofunction Group
Description: Demographic information form, vestibular tests, balance tests will be used in the evaluation. The demographic information form includes demographic information (name, surname, gender, smoking, alcohol use, etc.) and clinical conditions (past illnesses and/or surgeries, medications used, whether there is a history of falls, if any, frequency, whether they are afraid of heights and uncomfortable in the dark, etc.). The patients will be diagnosed with videonystagmography (VNG) after the decision of the ENT physician, and their hypofunction levels will be recorded. Vestibular and balance tests will be applied to the patients in the clinical setting. At the end of the study, it will be examined whether there is a relationship between the degree of vestibular hypofunction and the vestibular tests applied in the clinic.
Study NCT05755204 — intervention group
Intervention type: DRUG
Intervention: LA-CAB
Description: Intramuscular LA-CAB for PrEP
Study NCT05755204 — intervention group
Intervention type: DRUG
Intervention: TDF/FTC
Description: Oral TDF/FTC for PrEP
Study NCT04577027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Topical travoprost 0.004% solution
Description: 30 Patches treated with Topical Travoprost 0.004% solution: Topical travoprost 0.004% solution once daily (1 drop for each 2.5 x 2.5 cm2) for 3 months.
Study NCT04577027 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser
Description: 30 Patches treated with Fractional CO2 laser: Fractional CO2 laser sessions twice monthly for 3 months, parameters settings as follows: Energy\\ dot 100mj, pulse duration 5ms, density level 17, pattern: array, depth level 1, 2 passes used
Study NCT04577027 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Excimer laser
Description: 30 Patches treated with Excimer laser: Excimer laser sessions will be repeated twice weekly on the selected patch only, The starting dose will be 200 mj /cm2, an increase of 100 mJ/cm2 in the following session if no erythema appears, an increase of 50 mJ/cm2 every session till the appearance of erythema that lasts 24 hours or more.
Study NCT04577027 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combination therapy
Description: 30 Patches treated with Combination therapy: Fractional CO2 laser twice per month followed by application of topical travoprost 0,004% daily and excimer laser twice weekly .
Study NCT04577027 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Excimer laser and travoprost
Description: 30 Patches treated with Excimer laser twice weekly and topical travoprost once daily for 3 months
Study NCT04577027 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: fractional CO2 laser and topical travoprost
Description: 30 Patches treated with fractional CO2 laser twice monthly and topical travoprost once daily for 3 months
Study NCT05323162 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: encapsulated autologous fecal microbiota transplantation
Description: Individuals will recieve encapsulated freezedried own fecal microbiota to potentially extingish auto-immunity directed against the residual beta cell fraction
Study NCT05733065 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: saliva sample
Description: Adult twins will be asked to send saliva samples in a reply envelope to Maastricht University, department of Genetics and Cell Biology, where they will be frozen and stored before analysis. DNA will be extracted from the saliva using a commercially available kit according to the manufacturer's instructions.
Study NCT05733065 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: questionnaire
Description: Along with saliva samples, adult twins, will be asked to complete a questionnaire about their health. Study subjects will be asked to self-report height and weight. Additionally, questions will focus on cardiometabolic risk, including questions about smoking, physical activities, medical diagnoses, current medications, family history of cardiometabolic disease, and for female twins an obstetric and gynaecological history, including number of pregnancies and pregnancy complications (such as gestational diabetes and pre-eclampsia). The questionnaire will take the form of a self-completed, web-based questionnaire which will be hosted by the Qualtrics platform (Qualtrics.com). This platform is supported by the University of Maastricht due to its security and privacy measures.
Study NCT05526196 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Cannabis
Description: Dried flower cannabis cigarette with 22% THC
Study NCT05526196 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Tobacco
Description: Dried flower cigarette with active nicotine
Study NCT05526196 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Cannabis tobacco
Description: Dried flower cigarette with active nicotine and cannabis
Study NCT05526196 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Placebo
Description: Dried flower cigarette with both placebo tobacco and cannabis
Study NCT04059705 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dual-Task Training
Description: The ThinkFIT intervention will involve two days per week participation in simultaneous cognitive and motor training activities, facilitated by the SMARTFit Multisensory FItness System.
Study NCT05606874 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pre-heating of flowable resin composite used as a pit and fissure sealant.
Description: The occlusal fissures will be etched with a 37% phosphoric acid gel for 30 s. After rinsing the enamel with water for 30 s the enamel will be dried for 15 s with compressed air. After completing the fissure preparations a single coat of adhesive (3M ESPE ADPER ,USA) will be applied to the etched surface ,dried under gentle air flow for 2- 3 s and light cured for 20 s using a LED light curing unit with a 1000 mw output .Conventional resin fissure sealant (total etch), (UltraSeal XT®, Ultradent, USA) will be applied to the etched pits and fissures. After removing the rubber dam the occlusion will be checked the sealant will be adjusted with a composite finishing bur and polished with polishing points.
Study NCT04720352 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active treatment
Description: Active treatment delivers radiofrequency and cryogen
Study NCT04720352 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Sham delivers non therapeutic levels of radiofrequency and cryogen
Study NCT04788563 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heat-sensitive moxibustion plus original antihypertensive treatment (compulsively randomized arm)
Description: In this group, patients will self-administer heat-sensitive moxibustion or have family members help with the administration for six months. During this period, they will maintain their original antihypertensive treatment.
Study NCT04788563 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Original antihypertensive treatment (compulsively randomized arm)
Description: In this group, patients will maintain their original antihypertensive treatment.
Study NCT04788563 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heat-sensitive moxibustion plus antihypertensive treatment (voluntarily randomized arm)
Description: In this group, patients will self-administer heat-sensitive moxibustion or have family members help with the administration for six months. During this period, they will maintain their original antihypertensive treatment.
Study NCT06503250 — intervention group
Intervention type: DRUG
Intervention: Atezolizumab
Description: Observational Study
Study NCT06503250 — intervention group
Intervention type: DRUG
Intervention: Bevacizumab
Description: Observational Study
Study NCT06503250 — intervention group
Intervention type: RADIATION
Intervention: Transarterial Chemoembolization
Description: Observational Study
Study NCT04788563 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Original antihypertensive treatment (voluntarily randomized arm)
Description: In this group, patients will maintain their original antihypertensive treatment.